Indication
Macular Telangiectasia Type 2
4 clinical trials
1 product
Product
NT-501Clinical trial
A Phase III Multicenter Randomized, Sham Controlled, Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2Status: Completed, Estimated PCD: 2022-08-31
Clinical trial
Phase II, Multicenter, Open-label Safety Study of Bilateral NT-501 in Participants With Macular Telangiectasia Type 2Status: Completed, Estimated PCD: 2022-12-23
Clinical trial
A Phase III Multicenter Randomized, Sham Controlled, Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2Status: Completed, Estimated PCD: 2022-08-31
Clinical trial
A Multicenter Study to Determine the Safety and Efficacy of NT-501 Utilizing the Medica Membrane in Macular Telangiectasia Type 2Status: Not yet recruiting, Estimated PCD: 2026-04-27